Microbiome is a collective genome of microorganisms that reside inside and outside of the body, ranging from pathogenic to beneficial.
This report contains market size and forecasts of Microbiome Therapies in Global, including the following market information:
Global Microbiome Therapies Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Microbiome Therapies market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Bacteria Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Microbiome Therapies include uBiome, Evolve BioSystems, Indigo Agriculture, Pivot Bio, Concentric Ag, Epibiome, CosmosID, Human Longevity and Ajinomoto Cambrooke and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Microbiome Therapies companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Microbiome Therapies Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Microbiome Therapies Market Segment Percentages, by Type, 2021 (%)
Bacteria
Fungi
Virus
Others
Global Microbiome Therapies Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Microbiome Therapies Market Segment Percentages, by Application, 2021 (%)
Testing Centres
Research Labs
Horticulture
Others
Global Microbiome Therapies Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Microbiome Therapies Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Microbiome Therapies revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Microbiome Therapies revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
uBiome
Evolve BioSystems
Indigo Agriculture
Pivot Bio
Concentric Ag
Epibiome
CosmosID
Human Longevity
Ajinomoto Cambrooke
AnimalBiome